DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Crestor (Rosuvastatin) - Adverse Event Reports - Life Threatening Events - Cardiac Failure

 



Index of reports > Cases resulting in life threatening events (58) > Cases with Cardiac Failure (7)

Below is the selection of adverse event reports related to Crestor (Rosuvastatin) that includes cases resulting in life threatening events where reactions include cardiac failure.

Adverse event in male receiving Crestor (Rosuvastatin)

Reported by a physician from Japan on 2007-10-22

Patient: male, weighing 64.0 kg (140.8 pounds)

Adverse reactions / side effects: Cardiac Failure, Atrial Fibrillation

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Crestor
    Administration route: Oral
    Indication: Hypercholesterolaemia
    Start date: 2006-06-17
    End date: 2007-03-06

Crestor
    Administration route: Oral
    Start date: 2007-03-21

Other drugs received by patient: Aspirin; Ticlopidine HCL; Renivace; Amlodipine; Mucodyne; Astomin



Adverse event in male receiving Crestor (Rosuvastatin)

Reported by a physician from Japan on 2007-06-18

Patient: male, weighing 60.2 kg (132.4 pounds)

Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Dyspnoea, Cellulitis, Hepatic Function Abnormal, Visual Field Defect, Alanine Aminotransferase Increased, Hemiparesis, Dysarthria, Cardiac Failure, Cerebral Infarction, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Coronary Artery Restenosis, Aspartate Aminotransferase Increased

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Crestor
    Administration route: Oral
    Indication: Hypercholesterolaemia
    Start date: 2005-12-21
    End date: 2006-03-02

Crestor
    Administration route: Oral
    Start date: 2006-03-28
    End date: 2006-07-03

Crestor
    Administration route: Oral
    Start date: 2006-07-04
    End date: 2006-12-03

Other drugs received by patient: NU-Lotan; Allopurinol; Omepral; Euglucon; Cardenalin; Amlodin; Ticlopidine HCL; Prorenal; Sigmart; Aspirin; Pursennid; Mevalotin; Nitorol; Nitroderm; Albuminar; Predopa; Liple; Alprostadil; Metilon; Lasix; Mucodyne; Bisolvon; Hanp; Perdipine; Cefamezin Alpha



Adverse event in female receiving Crestor (Rosuvastatin)

Reported by a physician from Japan on 2007-03-08

Patient: female

Adverse reactions / side effects: Hepatic Function Abnormal, Cardiac Failure

Adverse event resulted in: life threatening event, disablity

Suspect drug(s):
Crestor (Rosuvastatin)

Other drugs received by patient: Mevalotin; Norvasc; Amaryl; Olmetec



Adverse event in female receiving Crestor (Rosuvastatin)

Reported by a physician from Japan on 2007-02-19

Patient: female

Adverse reactions / side effects: Hepatic Function Abnormal, Cardiac Failure

Adverse event resulted in: life threatening event, disablity

Suspect drug(s):
Crestor (Rosuvastatin)

Other drugs received by patient: Mevalotin; Norvasc; Amaryl; Olmetec



Adverse event in male receiving Crestor (Rosuvastatin)

Reported by a physician from Japan on 2007-02-07

Patient: male, weighing 60.2 kg (132.4 pounds)

Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Dyspnoea, Cellulitis, Hepatic Function Abnormal, Visual Field Defect, Alanine Aminotransferase Increased, Hemiparesis, Dysarthria, Cardiac Failure, Cerebral Infarction, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Coronary Artery Restenosis, Aspartate Aminotransferase Increased

Adverse event resulted in: life threatening event, hospitalization, disablity

Suspect drug(s):
Crestor
    Administration route: Oral
    Indication: Hypercholesterolaemia
    Start date: 2005-12-21
    End date: 2006-03-02

Crestor
    Administration route: Oral
    Start date: 2006-03-28
    End date: 2006-07-03

Crestor
    Administration route: Oral
    Start date: 2006-07-04
    End date: 2006-12-03

Other drugs received by patient: NU-Lotan; Zyloric; Omepral; Euglucon; Cardenalin; Amlodipine Besylate; Panaldine; Prorenal; Sigmart; Aspirin; Pursennid; Mevalotin; Nitorol; Nitroderm; Albuminar; Predopa; Liple; Alprostadil; Metilon; Lasix; Mucodyne; Bisolvon; Hanp; Perdipine; Cefamezin Alpha



Adverse event in female receiving Crestor (Rosuvastatin)

Reported by a physician from Japan on 2007-02-05

Patient: female

Adverse reactions / side effects: Hepatic Function Abnormal, Cardiac Failure

Adverse event resulted in: life threatening event, disablity

Suspect drug(s):
Crestor (Rosuvastatin)

Other drugs received by patient: Mevalotin; Norvasc; Amaryl; Olmetec



Adverse event in male receiving Crestor (Rosuvastatin)

Reported by a physician from Japan on 2007-01-30

Patient: male, weighing 60.2 kg (132.4 pounds)

Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Dyspnoea, Cellulitis, Hepatic Function Abnormal, Visual Field Defect, Alanine Aminotransferase Increased, Hemiparesis, Dysarthria, Cardiac Failure, Cerebral Infarction, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Coronary Artery Restenosis, Aspartate Aminotransferase Increased

Adverse event resulted in: life threatening event, hospitalization, disablity

Suspect drug(s):
Crestor
    Administration route: Oral
    Indication: Hypercholesterolaemia
    Start date: 2005-12-21
    End date: 2006-03-02

Crestor
    Administration route: Oral
    Start date: 2006-03-28
    End date: 2006-07-03

Crestor
    Administration route: Oral
    Start date: 2006-07-04
    End date: 2006-12-03

Other drugs received by patient: NU-Lotan; Zyloric; Omepral; Euglucon; Cardenalin; Amlodipine Besylate; Panaldine; Prorenal; Sigmart; Aspirin; Pursennid; Mevalotin; Nitorol; Nitroderm; Albuminar; Predopa; Liple; Alprostadil; Metilon; Lasix; Mucodyne; Bisolvon; Hanp; Perdipine; Cefamezin Alpha

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009